Ex-Juno chief Hans Bishop takes the helm at cancer testing startup Grail in a shakeup as IPO rumors percolate
There’s a shakeup underway at the high-flying cancer testing startup Grail which is bringing in one of the best known biotech execs in the industry.
Thursday evening Menlo Park, CA-based Grail announced that ex-Roche exec Jennifer Cook is stepping down from her post as CEO for family health reasons and handing the helm to Hans Bishop, best known for steering Juno Therapeutics to a $9 billion buyout by Celgene.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.